Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06682039 · ClinicalTrials.gov registry record · NA
Attention Bias Modification for the Improvement of Anxiety in Adolescent and Young Adult Cancer Survivors
A NA study of Childhood Malignant Solid Neoplasm and Childhood Hematopoietic and Lymphatic System Neoplasm, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT06682039 is a NA study of Childhood Malignant Solid Neoplasm and Childhood Hematopoietic and Lymphatic System Neoplasm that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 70 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06682039, a NA study of Childhood Malignant Solid Neoplasm and Childhood Hematopoietic and Lymphatic System Neoplasm, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial studies how well attention bias modification (ABM) improves anxiety in adolescent and young adult (AYA) cancer survivors. Cancer-related anxiety is the most prevalent mental health problem affecting AYA cancer survivors. Cancer-related anxiety is associated with long-term negative outcomes such as poor quality of life, depression, distress, substance use, sleep problems, fatigue, and pain. ABM uses techniques to help patients change the way they react to environmental triggers that may cause a negative reaction. ABM uses brief self-guided smartphone applications. Patients complete repetitive association reaction-time tasks targeting automatic and unconscious negative attention biases to retrain attention away from perceived threat and towards a neutral or positive stimuli. Gratitude-finding and savoring activities are also provided to maintain and increase positive emotions. Using ABM plus gratitude-finding and savoring activities may improve anxiety in AYA cancer survivors.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Interview
- OTHER Internet-Based Intervention
- OTHER Text Message-Based Navigation Intervention
Study Locations (1)
Washington
- Fred Hutch/University of Washington/Seattle Children's Cancer Consortium - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2024-11-08 |
| Est. Completion | 2026-01-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06682039
The ClinicalTrials.gov registry entry for NCT06682039 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Childhood Malignant Solid Neoplasm appearing as the primary indexed condition, and to 4 interventions - of which Questionnaire Administration is the first listed.
NCT06682039 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT06682039 about?
NCT06682039 is a clinical study titled "Attention Bias Modification for the Improvement of Anxiety in Adolescent and Young Adult Cancer Survivors". This clinical trial studies how well attention bias modification (ABM) improves anxiety in adolescent and young adult (AYA) cancer survivors. Cancer-related anxiety is the most prevalent mental health problem affecting AYA cancer survivors. Cancer-related anxiety is associated with long-term negativ...
What is the current status of trial NCT06682039?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2024-11-08. Estimated completion is 2026-01-12.
What conditions does trial NCT06682039 study?
This clinical trial studies the following conditions: Childhood Malignant Solid Neoplasm, Childhood Hematopoietic and Lymphatic System Neoplasm.
What interventions are being tested in trial NCT06682039?
The interventions under investigation include: Questionnaire Administration (OTHER), Interview (OTHER), Internet-Based Intervention (OTHER), Text Message-Based Navigation Intervention (OTHER).
Who is sponsoring clinical trial NCT06682039?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06682039 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Childhood Malignant Solid Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Childhood Malignant Solid Neoplasm
All registered trials for this condition
Childhood Hematopoietic and Lymphatic System Neoplasm
All registered trials for this condition
Washington
All trials with a study site in Washington
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.